Show simple item record

dc.contributor.authorBaum, Fran
dc.contributor.authorSanders, David
dc.contributor.authorFisher, Matt
dc.contributor.authorAnaf, Julia
dc.contributor.authorFreudenberg, Nicholas
dc.contributor.authorFriel, S.
dc.contributor.authorLabonte, Ronald
dc.contributor.authorLondon, Leslie
dc.contributor.authorMonteiro, Carlos
dc.contributor.authorScott-Samuel, Alex
dc.contributor.authorSen, Amit
dc.date.accessioned2016-06-23T09:36:16Z
dc.date.available2016-06-23T09:36:16Z
dc.date.issued2016
dc.identifier.citationBaum, F.E. (et al). Assessing the health impact of transnational corporations: its importance and a framework. Globalization and Health, 12: 27en_US
dc.identifier.issn1744-8603
dc.identifier.urihttp://hdl.handle.net/10566/2332
dc.description.abstractBACKGROUND: The adverse health and equity impacts of transnational corporations' (TNCs) practices have become central public health concerns as TNCs increasingly dominate global trade and investment and shape national economies. Despite this, methodologies have been lacking with which to study the health equity impacts of individual corporations and thus to inform actions to mitigate or reverse negative and increase positive impacts. METHODS: This paper reports on a framework designed to conduct corporate health impact assessment (CHIA), developed at a meeting held at the Rockefeller Foundation Bellagio Center in May 2015. RESULTS: On the basis of the deliberations at the meeting it was recommended that the CHIA should be based on ex post assessment and follow the standard HIA steps of screening, scoping, identification, assessment, decision-making and recommendations. A framework to conduct the CHIA was developed and designed to be applied to a TNC's practices internationally, and within countries to enable comparison of practices and health impacts in different settings. The meeting participants proposed that impacts should be assessed according to the TNC's global and national operating context; its organisational structure, political and business practices (including the type, distribution and marketing of its products); and workforce and working conditions, social factors, the environment, consumption patterns, and economic conditions within countries. CONCLUSION: We anticipate that the results of the CHIA will be used by civil society for capacity building and advocacy purposes, by governments to inform regulatory decision-making, and by TNCs to lessen their negative health impacts on health and fulfil commitments made to corporate social responsibility.en_US
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.source.urihttp://dx.doi.org/10.1186/s12992-016-0164-x
dc.subjectHealth impact assessment, Health inequalities, Public health policy, Health promotion, Methodologyen_US
dc.titleAssessing the health impact of transnational corporations: its importance and a frameworken_US
dc.typeArticleen_US
dc.privacy.showsubmitterFALSE
dc.status.ispeerreviewedTRUE
dc.description.accreditationISIen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/